
PRAZIQUANTEL AND RIFAMPICIN (RIFAMPIN)
Plasma levels of praziquantel are markedly reduced by rifampicin pretreatment, to undetectable levels in over half of the subjects in one study.
It is predicted that rifampicin will reduce the efficacy of praziquantel, and therefore the combination should be avoided.
It is predicted that rifampicin will reduce the efficacy of praziquantel, and therefore the combination should be avoided.